Novel microbially triggered colon specific delivery system of 5-Fluorouracil: Statistical optimization, in vitro, in vivo, cytotoxic and stability assessment

International Journal of Pharmaceutics

Volumn 411, Issue 1-2, 2011, Pages 142-151

  Dev, Rakesh Kumar ^a   Bali, Vikas ^a   Pathak, Kamla ^a  

^a Rajiv Academy for Pharmacy   (India)

Author keywords

5 Fluorouracil; Colon; Matrix tablet; Pectin; Targeting

Indexed keywords

EUDRAGIT; FLUOROURACIL; PECTIN; STARCH;

ARTICLE; CANCER CELL; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; FACTORIAL DESIGN; HARDNESS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOGRAPHY; RAT; SHELF LIFE; TABLET FRIABILITY; THICKNESS; WEIGHT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; COLON; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; FLUOROURACIL; HT29 CELLS; HUMANS; PECTINS; PHYSICOCHEMICAL PHENOMENA; RABBITS; RATS; RESEARCH DESIGN; STARCH; TABLETS;

EID: 79955962941     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.03.057     Document Type: Article

References (22)

1. Adkin, D.A., Kenyon, C.J., Lerner, E.I., Landau, I., Strauss, E., Caron, D., 1997. The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery. Pharm. Res. 14, 103-107.
2. Ahrabi, S.F., Madsen, G., Dyrstad, K., Sande, S.A., Graffer, C., 2000. Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. Eur. J. Pharm. Sci. 10, 43-52.
3. Calabresi, P., Chabner, B.A., 1996. Chemotherapy of neoplastic diseases. In: Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Gilman, A.G. (Eds.), Goodman and Gillman's The Pharmacologial Basis of Therapeutics. TheMcGraw-Hill Companies, Inc., pp. 1225-1232.
4. Dahm, C.C., Keogh, R.H., Spencer, E.A., Greenwood, D.C., Key, T.J., Fentiman, I.S., Shipley, M.J., Brunner, E.J., Cade, J.E., Burley, V.J., Mishra, G., Stephen, A.M., Kuh, D., White, I.R., Luben, R., Lentjes, M.A., Khaw, K.T., Rodwell, Bingham, S.A., 2010. Dietary fiber and colorectal cancer risk: a nested case-control study using food diaries. J. Natl. Cancer Inst. 102, 614-626.
5. Diasio, R.B., Harris, B.E., 1989. Clinical pharmacology of 5-fluorouracil. Clin. Pharmacokinet. 16, 215-237.
6. Egras, A.M., Hamilton, W.R., Lenz, T.L., Monaghan, M.S. An evidence-based review of fat modifying supplemental weight loss products, doi:10.1155/2011/ 297315.
7. Ko, I.K., Kim, B.G., Awadallah, A., Mikulan, J., Lin, P., Letterio, J.J., Dennis, J.E., 2010. Targeting improves MSC treatment of inflammatory bowel disease. Mol. Ther. 18, 1365-1372.
8. Krishnaiah, Y.S.R., Satyanarayana, V., Dinesh, K.B., Karthikeyan, R.S., 2002. In vitro drug release studies on guar gum-based colon targeted oral drug delivery system of 5-fluorouracil. Eur. J. Pharm. Sci. 16, 185-192.
9. Krishnaiah, Y.S.R., Satyanarayana, V., Dinesh, K.B., Karthikeyan, R.S., Bhaskar, P., 2003. In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets. Eur. J. Pharm. Sci. 19, 355-362.
10. Monin, M., Pundarikakshudu, K., 2007. Design, development and in vitro evaluation of sennosides tablets containing pectin HPMC for colonic drug delivery. Ind. J. Pharm. Sci. 69, 394-401.
11. Patel, H.K., Nagle, A., Murthy, R.S.R., 2008. Characterization of calcium alginate beads of 5-fluorouracil for colon delivery. Asian J. Pharm. 2, 241-245.
12. Patel, M.M., Amin, A.F., 2011. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer. Drug Deliv. 18, 281-293.
13. Philip, A.K., Dubey, R.K., Pathak, K., 2008. Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach. J. Pharm. Pharmacol. 60, 607-613.
14. Rahman, Z., Kohli, K., Zhang, S.Q., Khar, R.K., Ali, M., Charoo, N.A., Tauseef, M., Shamsher, A.A.A., Mohammed, N.N., Repka, M.A., 2008. In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil. J. Pharm. Pharmacol. 60, 615-623.
15. Rowe, R.C., Sheskey, P.J., Owen, S.C., 2006. Handbook of Pharmaceutical Excipient, 5th ed. Pharmaceutical Press, pp. 507-508.
16. Sinha, V.R., Kumaria, R., 2001. Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 224, 19-38.
17. Sinha, V.R., Mittal, B.R., Bhutani, K.K., Kumria, R., 2004. Colonic drug delivery of 5- fluorouracil: an in vitro evaluation. Int. J. Pharm. 269, 101-108.
18. Sriamornsak, P., Thirawong, N., Weerapol, Y., Nunthanid, J., Sungthongjeen, S., 2007. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur. J. Pharm. Biopharm. 67, 211-219.
19. Thirawong, N., Nunthanid, J., Puttipipatkhachorn, S., Sriamornsak, P., 2007. Mucoadhesive properties of various pectins on gastrointestinal mucosa: an in vitro evaluation using texture analyzer. Eur. J. Pharm. Biopharm. 67, 132-140.
20. Wakerly, Z., Fell, J.T., Attwood, D., Parkins, D.A., 1996. In vitro evaluation of pectin-based colonic drug delivery systems. Int. J. Pharm. 129, 73-77.
21. Wei, H., Qing, D., De-Ying, C., Bai, X., Li-Fang, F., 2008. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int. J. Pharm. 348, 35-45.
22. Zhao, R., Li, J., 2010. Perspectives on the treatment of colorectal carcinoma. World J. Gastrointest. Oncol. 2, 229-234.